---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-095608"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:45:02.486768+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Longevity Health to merge with THPlasma in $59M all-stock deal; Biolabs terminated

## Summary
- Merger values THPlasma at $59M plus $20M earnout; Longevity shares at $3.00 (12% premium to July 11 close).
- THPlasma has 5 plasma centers; FY2025E revenue $10M, EBITDA $2M; FY2026E revenue $32M, EBITDA $7M.
- Post-closing (Q4 2025), Rajiv Shukla becomes Executive Chairman; George Chi becomes Co-Chairman & CEO.
- Prior merger with 20/20 Biolabs automatically terminated July 8, 2025; no termination fees.
- No cash condition precedent; approved by both boards, subject to stockholder and Nasdaq approvals.

## SEC filing metadata
- accession: 0000950170-25-095608
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 5.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017025095608/0000950170-25-095608-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017025095608/xage-20250708.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-095608
- JSON: https://secwatch.observer/filing/0000950170-25-095608.json
- Plain text: https://secwatch.observer/filing/0000950170-25-095608.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.